Pharmaceuticals, among other products, will not be subject to the reciprocal tariffs, according to a White House fact sheet ...

Trump announced a 10% tariff on all U.S. trading partners, in addition to higher reciprocal tariffs on the EU and China. But ...

Billionaire entrepreneur and co-founder of Cost Plus Drugs, Mark Cuban's apprehensions of having to raise medicine prices in response to Trump's reciprocal tariffs on India is put to rest.

Rights Mar 16, 2016 Mar 17, 2016 May 12, 2015 Rights ratio: 5 share for every 116 held at a price of Rs 245.0 Rights Aug 23, 2012-Jul 14, 2011 Rights ratio: 1 share for every 7 held at a price of Rs ...

JPMorgan would like to be lighter in IT positioning as it expects financial year 2026 to be a complete washout.

Nordic American Tankers offers a ~10% dividend yield, 21 Suezmax tankers, and strong performance amid global growth. Learn ...

GigaCloud Technology offers tremendous upside with its flexible platform, growing GMV, and strong balance sheet amid evolving ...

Solara Active Pharma Sciences Ltd., incorporated in the year 2017, is a Small Cap company (having a market cap of Rs 2,462.48 Crore) operating in Pharmaceuticals sector. Solara Active Pharma Sciences ...

Steel and aluminium articles, and automobiles and auto parts, on which Trump earlier announced blanket 25% tariffs, would be ...

BLRX READ THE FULL BLRX RESEARCH REPORT BioLineRx Ltd. (NASDAQ:BLRX) reported full-year 2024 results, with revenues reaching $28.9 million. As the company completes its commercialization transition of ...

Spark Therapeutics, a gene therapy pioneer based in Philadelphia’s University City, is laying off 337 employees, more than half its workforce, as part of a restructuring by its owner, Swiss ...

Martin says ‘key objective’ has been ‘to convey complexity of pharmaceutical story and how Ireland is part of ‘integrated supply chain’ ...